At 12 weeks, weight loss ranged from 2.6% to 11.3%, compared to a gain of 0.2% in the placebo group. Guggenheim analysts were ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

An experimental weight-loss drug from Eli Lilly & Co. helped patients lose weight with few side effects, according to the ...

Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...

Metsera has linked its amylin analog to 8.4% placebo-adjusted weight loss at Day 36, advancing its push to develop an ...

International small cap equities rose modestly in the first quarter as the outlooks for corporate spending and global economic growth were complicated by US tariff plans. The quarter proved to be ...

with analyst Prakhar Agrawal saying in a Friday note to clients that the stock was "trading at a meaningful valuation disconnect relative to the upcoming milestones for petrelintide and the multi ...

with analyst Prakhar Agrawal saying in a Friday note to clients that the stock was "trading at a meaningful valuation disconnect relative to the upcoming milestones for petrelintide and the multi ...